DK0727430T3 - Platinkomplekser - Google Patents

Platinkomplekser

Info

Publication number
DK0727430T3
DK0727430T3 DK96300601T DK96300601T DK0727430T3 DK 0727430 T3 DK0727430 T3 DK 0727430T3 DK 96300601 T DK96300601 T DK 96300601T DK 96300601 T DK96300601 T DK 96300601T DK 0727430 T3 DK0727430 T3 DK 0727430T3
Authority
DK
Denmark
Prior art keywords
carboxylate
hydroxy
platinum complexes
different
halo
Prior art date
Application number
DK96300601T
Other languages
English (en)
Inventor
Barry A Murrer
Original Assignee
Cancer Res Inst
Anormed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Res Inst, Anormed Inc filed Critical Cancer Res Inst
Application granted granted Critical
Publication of DK0727430T3 publication Critical patent/DK0727430T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Studio Devices (AREA)
DK96300601T 1995-02-14 1996-01-29 Platinkomplekser DK0727430T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9502799.1A GB9502799D0 (en) 1995-02-14 1995-02-14 Improvements in platinum complexes

Publications (1)

Publication Number Publication Date
DK0727430T3 true DK0727430T3 (da) 2001-09-03

Family

ID=10769529

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96300601T DK0727430T3 (da) 1995-02-14 1996-01-29 Platinkomplekser

Country Status (18)

Country Link
US (2) US5665771A (da)
EP (1) EP0727430B1 (da)
JP (1) JP3219235B2 (da)
KR (1) KR100339866B1 (da)
AT (1) ATE202111T1 (da)
AU (1) AU707814B2 (da)
CA (1) CA2169019C (da)
DE (1) DE69613254T2 (da)
DK (1) DK0727430T3 (da)
ES (1) ES2157399T3 (da)
FI (1) FI120493B (da)
GB (1) GB9502799D0 (da)
GR (1) GR3036513T3 (da)
NO (1) NO307569B1 (da)
NZ (1) NZ280946A (da)
PT (1) PT727430E (da)
TW (1) TW432068B (da)
ZA (1) ZA96885B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001872A (en) * 1999-03-05 1999-12-14 Virginia Commonwealth University Water soluble transplatinum complexes with anti-cancer activity and method of using same
US6413953B1 (en) * 1999-04-13 2002-07-02 Anormed Inc. Pt(IV) antitumor agent
PL202731B1 (pl) * 1999-04-13 2009-07-31 Anormed Sposób wytwarzania kompleksu cis-platynowego oraz kompleks cis-platynowy
CA2385528C (en) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
RU2186068C2 (ru) * 1999-12-02 2002-07-27 Институт химии и химической технологии СО РАН Способ очистки цис-дихлороамминизопропиламинплатины (ii)
AUPQ641100A0 (en) * 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
US6894049B1 (en) 2000-10-04 2005-05-17 Anormed, Inc. Platinum complexes as antitumor agents
RU2284818C2 (ru) * 2001-05-10 2006-10-10 Анормед, Инк. Комбинированная химиотерапия
ES2339228T3 (es) * 2001-08-23 2010-05-18 Yissum Research Development Company Of The Hebrew University Of Jerusalem Complejos de platino y sus usos en terapia.
US8324197B2 (en) * 2005-08-11 2012-12-04 Virginia Commonwealth University Transplatinum complexes with N2O2 donor sets as cytotoxic and antitumor agents
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8173686B2 (en) * 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168661B2 (en) * 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
CN101678046A (zh) * 2007-02-09 2010-03-24 帕纳德制药公司 稳定化的吡铂口服剂型
RU2009133447A (ru) * 2007-02-09 2011-03-20 Пониард Фармасьютикалз, Инк. (Us) Дозированная форма пикоплатина
US20110033528A1 (en) * 2009-08-05 2011-02-10 Poniard Pharmaceuticals, Inc. Stabilized picoplatin oral dosage form
TW200916094A (en) * 2007-06-27 2009-04-16 Poniard Pharmaceuticals Inc Stabilized picoplatin dosage form
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
WO2009011861A1 (en) * 2007-07-16 2009-01-22 Poniard Pharmaceuticals, Inc. Oral formulations for picoplatin
EP2249644A4 (en) * 2008-02-08 2012-05-30 Poniard Pharmaceuticals Inc PICOPLATIN AND AMRUBICIN FOR THE TREATMENT OF LUNG CANCER
RU2383339C1 (ru) * 2008-07-04 2010-03-10 Федеральное государственное учреждение "Ростовский научно-исследовательский онкологический институт Росмедтехнологий" Способ прогнозирования эффективности неоадъювантной химиотерапии при местнораспространенном раке яичников
CN101775040B (zh) * 2009-12-31 2012-05-09 南京臣功制药有限公司 吡铂的制备方法
US9771387B2 (en) 2013-07-16 2017-09-26 Placon Therapeutics Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof
CN106943343B (zh) * 2016-01-06 2020-05-12 山东新时代药业有限公司 一种甲啶铂注射液及其制备方法
WO2017192290A1 (en) 2016-05-04 2017-11-09 The Wistar Institute Of Anatomy And Biology Methods of treating cancers overexpressing carm1 with ezh2 inhibitors and platinum-based antineoplastic drugs

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1432562A (en) 1972-04-10 1976-04-22 Rustenburg Platinum Mines Ltd Platinum co-ordination compounds
KR840007599A (ko) * 1983-01-21 1984-12-08 마쓰바라 이찌로오 백금 착화합 유기물의 제조방법
US4533502A (en) * 1983-02-22 1985-08-06 Rochon Fernande D Platinum (II) compounds and their preparation
DE3582961D1 (de) * 1984-06-27 1991-07-04 Johnson Matthey Plc Platinkoordinationsverbindungen.
JPS61238795A (ja) * 1985-04-16 1986-10-24 エンゲルハード・コーポレーシヨン 白金トリアミン抗腫瘍剤
EP0273315B1 (en) * 1986-12-18 1992-03-18 SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. Ammine-n-heterocyclic-platinum complexes and antitumor agents
US4812193A (en) * 1986-12-22 1989-03-14 Gauron Richard F Inset panel fastener and method of using
ES2063119T3 (es) * 1988-02-02 1995-01-01 Johnson Matthey Inc Complejos de pt (iv).
GB8806044D0 (en) * 1988-03-14 1988-04-13 Johnson Matthey Plc Platinum coordination compounds
GB9105037D0 (en) * 1991-03-09 1991-04-24 Johnson Matthey Plc Improvements in chemical compounds
US5624919A (en) * 1993-09-14 1997-04-29 The University Of Vermont And State Agricultural College Trans platinum (IV) complexes
GB9408218D0 (en) * 1994-04-26 1994-06-15 Johnson Matthey Plc Improvements in platinum complexes
PL202731B1 (pl) * 1999-04-13 2009-07-31 Anormed Sposób wytwarzania kompleksu cis-platynowego oraz kompleks cis-platynowy
ES2339228T3 (es) * 2001-08-23 2010-05-18 Yissum Research Development Company Of The Hebrew University Of Jerusalem Complejos de platino y sus usos en terapia.
EP1789427B1 (en) * 2004-09-01 2009-05-20 Platco Technologies (Proprietary) Limited Preparation of platinum(ii) complexes
US8324197B2 (en) * 2005-08-11 2012-12-04 Virginia Commonwealth University Transplatinum complexes with N2O2 donor sets as cytotoxic and antitumor agents

Also Published As

Publication number Publication date
GR3036513T3 (en) 2001-12-31
US5665771A (en) 1997-09-09
CA2169019A1 (en) 1996-08-15
HK1011997A1 (en) 1999-07-23
ATE202111T1 (de) 2001-06-15
NO307569B1 (no) 2000-04-25
FI120493B (fi) 2009-11-13
USRE41209E1 (en) 2010-04-06
GB9502799D0 (en) 1995-04-05
KR960030940A (ko) 1996-09-17
NO960569L (no) 1996-08-15
TW432068B (en) 2001-05-01
FI960660L (fi) 1996-08-15
CA2169019C (en) 2003-02-04
ZA96885B (en) 1996-08-14
AU707814B2 (en) 1999-07-22
DE69613254T2 (de) 2001-09-20
JPH08259581A (ja) 1996-10-08
JP3219235B2 (ja) 2001-10-15
PT727430E (pt) 2001-11-30
FI960660A0 (fi) 1996-02-14
ES2157399T3 (es) 2001-08-16
NO960569D0 (no) 1996-02-13
EP0727430A1 (en) 1996-08-21
EP0727430B1 (en) 2001-06-13
NZ280946A (en) 1997-05-26
KR100339866B1 (ko) 2002-11-07
DE69613254D1 (de) 2001-07-19
AU4225896A (en) 1996-08-22

Similar Documents

Publication Publication Date Title
DE69613254D1 (de) Platinkomplexe
MY120235A (en) Aryloxyarylsulfonylamino hydroxamic acid derivatives
ATE205216T1 (de) Platinkomplexe
ATE266634T1 (de) Cyclobutyl-aryloxysulfonylamin- hydroxamsäurederivate
EP0599651A3 (en) Bioreactor for cell culture in perfusion.
PL326925A1 (en) Substituted aryl or heteroaryl amides exhibiting retin-like biological activity
TR200002445T2 (tr) Fosfolipaz inhibitörleri.
TR200800474T2 (tr) Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
EP1024502A4 (en) ELECTROLYTE COMPOSITION, ELECTROLYTE AND METHOD FOR THE PRODUCTION THEREOF, AND THE CELL CONTAINING IT
BR0211422A (pt) Processo para a preparação de um composto ou de um éster ou um sal do mesmo, e, composto
FI972074A0 (fi) Akrylamidderivat och foerfarande foer framstaellning daerav
DE59904884D1 (de) 4-trifluormethyl-3-oxazolylpyridine, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als schädlingsbekämpfungsmittel
DE60112309D1 (de) Verwendung von percarbaminsäure und diacylpercarbamaten und deren vorstufen
TR200101474T2 (tr) Yeni ara maddeler, bunlardan makrolid antibiyotik aktif madde hazırlanması.
DE69124844D1 (de) Radicicol-Derivate, ihre Herstellung und ihre Antitumorwirkung
DE3678086D1 (de) Rhizoxinderivate, ihre herstellung und pharmazeutische verwendung.
DE69031730D1 (de) Neues Antibiotikum, Deoxymulündocandin, Verfahren zu seiner Produktion und Verwendung als Medikament
ES8706112A1 (es) Un procedimiento para preparar derivados de 4 4-dialquil- -2-azetidinomas
ATE167869T1 (de) Thiolderivate von gallensäure
TR199701744T1 (xx) Ha�arat m�cadele maddesi olarak s�bstit�e edilmi� 1,3-Dioksan-5-�lamino-Heterosayk�llar�.
ATE73789T1 (de) Gegen anaerobe bakterien wirksame antibiotika, ihre produktion und enterobakter-staemme, die sie produzieren.
DE69729114D1 (de) 1,3-diphenylphosphinopropan-liganden und entsprechende übergangsmetallkomplexe, deren herstellung und verwendung
ATE215561T1 (de) Methylsulfomycin 1, verfahren zu dessen herstellung und verwendung
DE3667279D1 (de) 5-isoxazolcarbonsaeureamide, ihre herstellung und verwendung als fungizide.
DE69415700D1 (de) Strahlungsenergievorrichtung für die mikroklimatische Regulierung von isolierten Umgebungen bestimmt für Aquikultur, Hydrokultur und Gewächshauskultur